Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease.

O Winqvist, J Gustafsson, F Rorsman… - The Journal of …, 1993 - Am Soc Clin Investig
O Winqvist, J Gustafsson, F Rorsman, FA Karlsson, O Kämpe
The Journal of clinical investigation, 1993Am Soc Clin Investig
Autoimmune polyendocrine syndrome type I (APS I) and idiopathic Addison's disease are
both disorders with adrenal insufficiency but with differences in genetic background, clinical
presentation, and extent of extraadrenal manifestations. In this study the major adrenal
autoantigen identified with sera from patients with APS I was characterized by analyses
using indirect immunofluorescence, Western blots of adrenal subcellular fractions and of
recombinant proteins, immunoprecipitations of [35S] methionine-labeled lysates of a human …
Autoimmune polyendocrine syndrome type I (APS I) and idiopathic Addison's disease are both disorders with adrenal insufficiency but with differences in genetic background, clinical presentation, and extent of extraadrenal manifestations. In this study the major adrenal autoantigen identified with sera from patients with APS I was characterized by analyses using indirect immunofluorescence, Western blots of adrenal subcellular fractions and of recombinant proteins, immunoprecipitations of [35S]methionine-labeled lysates of a human steroid-producing cell line, and studies of enzymatic activity. Sera from patients with APS I, identifying cells in adrenal glands and testes involved in steroid synthesis, reacted in Western blots with a 53-kD antigen, which comigrated with the cytochrome P450 cholesterol side chain cleavage enzyme (SCC). The sera also immunoprecipitated this protein from lysates of radiolabeled adrenal cells. The enzymatic activity of SCC was inhibited by the APS I sera but not by control sera. Sera from patients with idiopathic Addison's disease did not react with the SCC. The results show that the autoimmune responses towards adrenal tissue in patients suffering from APS I and Addison's disease are remarkably selective and suggest that a determination of the antigen involved in a patient with autoimmune adrenal insufficiency will have diagnostic as well as prognostic implications.
Images
The Journal of Clinical Investigation